Latest From Kaiser Permanente
Point-of-care/near-patient testing has been “two years away from major breakthrough” for at least two decades, but fast access to data via automation and IT means that progress might change at last. How the tests are paid for remains an issue. The future of POC was the theme of an investor discussion at the first DxPx conference, held during the Medica 2019 event in Germany.
Amazon, Microsoft, IBM among those helping build new operations and innovation centers for the US FDA's safety surveillance system.
Sanofi says the virtual innovation lab it will create with Google will enable precision health care and optimize R&D and commercial operations. Incoming CEO Hudson has been tasked with improving the pharma’s R&D and digital capabilities.
Biopharma industry urges agency to open the door wider to use of non-randomized observational studies to support efficacy claims, but insurer Kaiser Permanente calls such studies problematic.
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Kaiser Permanente
- Senior Management
David M Lawrence, CEO
Robert E Briggs, SVP, CFO
Susan E Porth, SVP, Fin.
William Caswell, VP, Mktg. & Bus. Dev.
- Contact Info
Phone: (415) 271-5910
1 Kaiser Plaza
Oakland, CA 94612-2703
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.